Cox regression analysis indicated that FOXQ1 expression suggested good prognosis in bladder urothelial carcinoma, kidney renal papillary cell carcinoma, prostate adenocarcinoma, and uterine corpus endometrial carcinoma and poor prognosis in liver hepatocellular carcinoma, pancreatic adenocarcinoma, and skin cutaneous melanoma (Figure 3B). This evidence concerns the gene FOXQ1 and uterine corpus endometrial carcinoma.